Impact of Patient Assistance Programs on Financial Toxicity in Cancer Patients Managed Through Health System Specialty Pharmacies
Perspectives on financial toxicity, the role of the health system specialty pharmacy, and barriers associated with patient assistance programs
Faculty Chair
Bryan Schuessler, PharmD
Savings Solutions in Overland Park
More Information
- Virtual series
- South Dakota, Montana, Minnesota, Utah, New Jersey, Massachusetts, Missouri, California
REPORT SNAPSHOT
- A virtual, moderated roundtable discussion focusing on financial hardships attributed to prescription drug regimens
- Insights were obtained on factors impacting PAP selection, impact of barriers leading to financial toxicity, and PAP support needs
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection was accomplished through use of audience response system questioning and moderated discussion
- The group of advisors comprised 10–15 medical oncologists and pharmacists representative of each region